COmBining Memantine And Cholinesterase Inhibitors In Lewy Body Dementia Treatment Trial (COBALT)
Funder
National Health and Medical Research Council
Funding Amount
$1,218,120.00
Summary
Many people who have been diagnosed with dementia with Lewy bodies or Parkinson’s disease dementia will be prescribed drugs known as acetylcholinesterase inhibitors (e.g. donepezil, rivastigmine, galantamine) to help with their symptoms. This research trial, known as COBALT, is designed to find out whether there is any benefit from taking the drug memantine as well. Australian and UK researchers are collaborating on this trial which will recruit eligible participants from both countries.
Developing And Testing A Community-informed Intervention To Increase VIA Cervical Cancer Screening In Eswatini
Funder
National Health and Medical Research Council
Funding Amount
$1,206,528.00
Summary
Eswatini has the highest rate of cervical cancer in the world. Cervical cancer screening is effective at reducing deaths from this disease. However, in Eswatini rates of cervical screening are very low, with one study estimating that only 5% of women had ever undergone screening. This project will explore barriers to cervical screening in Eswatini, and develop and test culturally appropriate strategies to improve participation in cervical screening.
DigiCare4You - An Intersectoral Innovative Solution Involving DIGItal Tools, Empowering Families And Integrating Community CARE Services For The Prevention And Management Of Type 2 Diabetes And Hypertension
Funder
National Health and Medical Research Council
Funding Amount
$489,307.00
Summary
The overall aim of the research is to design and implement an innovative intervention that will bring together the available community-care infrastructure, human resources and services, as well as technological advancements on digital health, for the early prevention and treatment of type 2 diabetes and hypertension. The active involvement of Australian researchers in this international collaboration ensures that this innovation and its benefits will be transferred to Australia in the future.